Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Naturecan is a global wellness company specializing in the production and distribution of high-quality hemp-derived CBD products and nutritional supplements. Founded in 2019 by former Myprotein CEO Andy Duckworth and Paul Finnegan, the company focuses on delivering safe, effective, and lab-tested alternatives for pain management, anxiety, and sleep support. Their extensive product range includes CBD oils, topicals, gummies, and vitamins, all sourced from hemp grown in the United States under strict quality controls. Naturecan distinguishes itself through a commitment to transparency, utilizing advanced purification processes to ensure 0.0% THC content in its broad-spectrum offerings. The company currently operates in over 40 countries, positioning itself as a leader in the rapidly growing consumer cannabinoid market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Naturecan.